(All fields required)
Please enter a valid email.
Please enter your name.
You are here because the page you have requested doesn't exist, at least not at the requested location.
Perhaps the following search results will help:
... The drug has proven safe even for very young children -- in fact, the NIH will revise treatment guidelines this year to include hydroxyurea as ...
www.cincinnatichildrens.org/about/corporate/annual-reports/2014/sickle-cell-disease-uganda/ - 109k - 2015-03-30
... medicine,� she says. �Or I would like to have an ongoing partnership with a hospital or clinic there.�. For More Information. ...
www.cincinnatichildrens.org/about/corporate/annual-reports/2014/global-health-residency/ - 90k - 2015-03-30
... New information about the genetics and molecular biology of tuberous sclerosis made this progress possible. ... In fact, tumors shrunk in all 28 patients ...
www.cincinnatichildrens.org/about/corporate/annual-reports/2012/tuberous-sclerosis/ - 102k - 2015-03-30
... 11:38:52 PM. Corporate InformationAnnual Reports, Facts and Figures; Outcomes and QualityThe path to transformational change; ...
www.cincinnatichildrens.org/about/default/ - 71k - 2015-03-31
... In fact, the research this technology enables is so new, researchers using it often are not eligible for funding from traditional sources, such as the ...
www.cincinnatichildrens.org/about/corporate/annual-reports/2013/infant-mri/ - 71k - 2015-03-30
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center